June 18, 2013

The Food and Drug Administration's Center for Drug Evaluation and Research has collected 84% of the fees it intends to collect this year under a law passed last year to collect user fees from generic drug members, according to a memo sent out to CDER staff Tuesday.

June 18, 2013

Teva Pharmaceutical Industries will spend up to $165 million to buy a company developing a drug to prevent viral respiratory infections.

June 17, 2013

Perrigo Co. will pay up to $129 million to buy Fera Pharmaceuticals' portfolio of ophthalmic products, Perrigo said.

June 17, 2013

Patent settlements between brand and generic drug makers commonly referred to as "pay-for-delay" settlements are not necessarily against the law, the Supreme Court ruled Monday.

June 12, 2013

Meijer will open two new stores in northern Indiana, the mass merchandise retailer said.

June 12, 2013

Google has removed advertisements for websites that sell drugs without prescriptions, following a series of warning letters from a state attorney general, according to published reports.

June 12, 2013

Pfizer will receive more than $2 billion from Teva Pharmaceutical Industries and Sun Pharmaceutical Industries to settle a case concerning a gastroesophageal reflux disease drug.

June 12, 2013

Walgreens on Wednesday reached an agreement settling DEA concerns relating to the distribution and dispensing of controlled substances.

June 11, 2013

Aceto Corp. will sell an authorized generic version of a drug used to treat a rare but devastating degenerative disorder.

June 11, 2013

The Annals of Internal Medicine published a study comparing generic utilization of common diabetes medications across two government programs — Medicare Part D and the U.S. Department of Veterans Affairs.

June 7, 2013

Actavis is hoping to become the first to market generic versions of a contraceptive and a sedative, the drug maker said.

June 6, 2013

MySugr Companion, one of Europe's leading and award-winning diabetes apps for iPhone, is now available for download in the U.S. App Store, the app developer announced.

June 6, 2013

Supermarket operator Ahold USA has completed rolling out prescription-savings cards at the chains it operates with the introduction of the cards in Giant Food Stores.

June 5, 2013

South Korean drug maker Hanmi Pharmaceutical Co. and U.S. partner Amneal Pharmaceuticals have made an agreement in federal court concerning a generic heartburn drug.

June 5, 2013

Most Americans have little understanding of the importance of managing fats known as triglycerides to maintain cardiovascular health, according to a new survey.

June 4, 2013

At the 2013 Business and Leadership Conference in Orlando, Fla., HDMA honored pharmaceutical and consumer product manufacturers during the presentation of the 2013 Distribution Industry Awards for Notable Achievements in Healthcare.

June 4, 2013

The House of Representatives voted Monday to pass a bill that would establish national standards for the pharmaceutical supply chain.

June 4, 2013

A lot is said about how pharmacists are the most accessible healthcare professionals, and one health insurer is taking advantage of this by sponsoring a series of special seminars for elderly people.

June 4, 2013

A subsidiary of Aceto Corp. has launched a generic treatment for seasonal and perennial allergies, the company said Tuesday.

June 3, 2013

Dr. Reddy's Labs and Fujifilm have terminated a deal to market generic drugs in Japan, Dr. Reddy's said.

June 3, 2013

Another bill to limit dispensing of biosimilars lost Monday, this time in Illinois.

May 31, 2013

Antitrust attorney and pharmacy benefit management legal expert David Balto on Friday monitored a mini-summit helping supermarket pharmacy better navigate the PBM universe.

May 31, 2013

There are several important pieces of legislation that will have an impact on the business of supermarket pharmacy if passed, noted Michael Spira, American Pharmacists Association senior lobbyist, during an FMI education session.

May 31, 2013

India-based Sun Pharmaceutical Industries may buy Sweden-based Meda for $5 billion to $6 billion, according to published reports.